# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000912282-15-000398
Filing Date
2015-10-28
Accepted
2015-10-28 14:58:22
Documents
10
Period of Report
2015-09-25

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | oncolytics6k_10282015.htm | 6-K | 22571
2 | UNDERTAKING TO THE EXECUTIVE DIRECTOR DATED 20150925 | ex99_1.htm | EX-99.1 | 7897
3 |  | undertaking_p1.jpg | GRAPHIC | 260363
4 |  | undertaking_p2.jpg | GRAPHIC | 316306
5 |  | undertaking_p3.jpg | GRAPHIC | 246609
6 |  | undertaking_p4.jpg | GRAPHIC | 258078
7 |  | undertaking_p5.jpg | GRAPHIC | 225298
8 |  | undertaking_p7.jpg | GRAPHIC | 229376
9 |  | undertaking_p8.jpg | GRAPHIC | 169923
10 |  | undertakingp_6.jpg | GRAPHIC | 255447
| Complete submission text file | 0000912282-15-000398.txt |  | 2733971

Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 151180015
SIC: 2834 Pharmaceutical Preparations